Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia

Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia

Patients affected by the rare Glanzmann thrombasthenia (GT) suffer from defective or low levels of the platelet-associated glycoprotein (GP) IIb/IIIa, which acts as a fibrinogen receptor, and have therefore an impaired ability to aggregate platelets. Because the procoagulant activity is a dichotomou...

Full description

Bibliographic Details
Main Authors:	Alessandro Aliotta, Manuel Krüsi, Debora Bertaggia Calderara, Maxime G. Zermatten, Francisco J. Gomez, Ana P. Batista Mesquita Sauvage, Lorenzo Alberio
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	International Journal of Molecular Sciences
Subjects:	procoagulant platelets Glanzmann thrombasthenia procoagulant activity ion fluxes
Online Access:	https://www.mdpi.com/1422-0067/21/24/9515

Similar Items

Thrombocytopathies: Not Just Aggregation Defects—The Clinical Relevance of Procoagulant Platelets
by: Alessandro Aliotta, et al.
Published: (2021-02-01)

Mechanisms Underlying Dichotomous Procoagulant COAT Platelet Generation—A Conceptual Review Summarizing Current Knowledge
by: Lucas Veuthey, et al.
Published: (2022-02-01)

Peripartum Management of a Pregnant with Glanzmann’s Thrombasthenia: A Case Report
by: Seda Ateş, et al.
Published: (2014-09-01)

Clinical Management of Glanzmann's Thrombasthenia: A Case Report.
by: Indu Varkey, et al.
Published: (2014-04-01)

Management of siblings with Glanzmann's thrombasthenia: A case report
by: Mebin George Mathew
Published: (2020-01-01)

Recognition and management of platelet-refractory bleeding in patients with Glanzmann’s thrombasthenia and other severe platelet function disorders
by: Chitlur M, et al.
Published: (2017-04-01)

Glanzmann Thrombasthenia Associated with Siderotic Synovitis and Arthropathy: A Case Report
by: Alawad MJ, et al.
Published: (2023-11-01)

Glanzmann thrombasthenia—A not so rare platelet function disorder in Pakistan
by: Rafia Mahmood, et al.
Published: (2022-12-01)

Glanzmann thrombasthenia and its perioperative management in head trauma: A rare and challenging situation
by: Neeraj Kumar, et al.
Published: (2016-01-01)

Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann Thrombasthenia
by: Francesco Paciullo, et al.
Published: (2021-02-01)

Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpression
by: Liang Hu, et al.
Published: (2017-04-01)

Thalidomide for the treatment of gastrointestinal bleeding due to angiodysplasia in a patient with Glanzmann’s thrombasthenia
by: Bruno K.L. Duarte, et al.
Published: (2017-06-01)

Glanzmann’s Thrombasthenia: Role of Angioembolization and factor VII in recurrent bleeding from ulcerated duodenum
by: Ali Abbas, et al.
Published: (2016-06-01)

Management of Glanzmann's Thrombasthenia – Guidelines based on an expert panel consensus from gulf cooperation council countries
by: Ahmad Tarawah, et al.
Published: (2019-01-01)

Spontaneous intramural duodenal hematoma resulting from Glanzmann's thrombasthenia
by: Soo-Hong Kim, et al.
Published: (2017-12-01)

Glanzmann thrombasthenia: Use of hemocoagulase (BotroClot) for arrest of bleeding during a primary tooth endodontic procedure
by: Lalitha S Jairam, et al.
Published: (2022-01-01)

GLANZMANNS THROMBASTHENIA
by: ZUHAIR AL-BARAZANCHImad
Published: (2009-06-01)

Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient
by: Richa Chauhan, et al.
Published: (2018-02-01)

Perioperative management of a patient with glanzmann's thrombasthenia for mitral valve repair under cardiopulmonary bypass
by: Parimala Prasanna Simha, et al.
Published: (2017-01-01)

Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?
by: Nurden A
Published: (2021-07-01)

Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity
by: Jens Van Bael, et al.
Published: (2023-04-01)

Young steady-state rabbit platelets do not have an enhanced capacity to expose procoagulant phosphatidylserine
by: Emily C. Reddy, et al.
Published: (2018-01-01)

Glanzmann Thrombasthenia in Pakistani Patients: Identification of 7 Novel Pathogenic Variants in the Fibrinogen Receptor αIIbβ3
by: Muhammad Younus Jamal Siddiqi, et al.
Published: (2023-01-01)

The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes
by: Rainer B. Zotz, et al.
Published: (2019-07-01)

Glanzmann thrombasthenia associated with human immunodeficiency virus-positive patient
by: Rakesh Kumar Manne, et al.
Published: (2014-01-01)

Identification of one novel pathogenic ITGB3 mutation and two known mutations in two Chinese pedigrees with hereditary Glanzmann thrombasthenia
by: Zhengjing Lu, et al.
Published: (2020-04-01)

Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report
by: Elizabeth Sarah Mayne, et al.
Published: (2018-11-01)

Glanzmann's thrombasthenia – A rare case report of spontaneous gingival bleeding
by: Vijayalakshmi Venkat, et al.
Published: (2018-01-01)

Glanzmann's thrombasthenia during pregnancy complicated by large subchorionic hematoma managed with antifibrinolytics, human leukocyte antigen-matched platelet transfusion, and primary cesarean delivery: a case report
by: Veronica Winget, MD, MS, et al.
Published: (2022-02-01)

Identification of three novel pathogenic ITGA2B and one novel pathogenic ITGB3 mutations in patients with hereditary Glanzmann’s thrombasthenia living in Eastern Turkey
by: Kamuran Karaman, et al.
Published: (2021-02-01)

Successful Treatment of Refractory Gastrointestinal Bleeding by Systemic (Oral) Ankaferd Blood Stopper in a Patient with Glanzmann Thrombasthenia
by: Sibel Kabukçu Hacıoğlu, et al.
Published: (2015-06-01)

Carbonic Anhydrase Inhibitors suppress platelet procoagulant responses and in vivo thrombosis: Carbonic Anhydrase Inhibitors as Antithrombotics
by: Ejaife O. Agbani, et al.
Published: (2020-10-01)

Differential Antivenom and Small-Molecule Inhibition of Novel Coagulotoxic Variations in <i>Atropoides, Cerrophidion, Metlapilcoatlus,</i> and <i>Porthidium</i> American Viperid Snake Venoms
by: Lee Jones, et al.
Published: (2022-07-01)

Levonorgestrel-releasing intrauterine system for treatment of heavy menstrual bleeding in adolescents with Glanzmann’s Thrombasthenia: illustrated case series
by: Meiqiu Lu, et al.
Published: (2018-02-01)

Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients
by: Bibian M. E. Tullemans, et al.
Published: (2018-10-01)

Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia
by: Zhengrong Wang, et al.
Published: (2023-01-01)

Adrenaline May Contribute to Prothrombotic Condition via Augmentation of Platelet Procoagulant Response, Enhancement of Fibrin Formation, and Attenuation of Fibrinolysis
by: Agata Golaszewska, et al.
Published: (2021-05-01)

Platelet Subtypes in Inflammatory Settings
by: Muataz Ali Hamad, et al.
Published: (2022-04-01)

Curcumin at Low Doses Potentiates and at High Doses Inhibits ABT-737-Induced Platelet Apoptosis
by: Natalia Rukoyatkina, et al.
Published: (2021-05-01)

Utility of the Platelet Function Analyzer in Patients with Suspected Platelet Function Disorders: Diagnostic Accuracy Study
by: Jonas Kaufmann, et al.
Published: (2020-10-01)